SYSMEX CORP.UNSP.ADR 1/2 (0YX0 F) stock market data APIs
€6.5184
0(0%)
as of February 26, 2026
Try our APIs with
free plan!
SYSMEX CORP.UNSP.ADR 1/2 Financial Data Overview
Price chart is built with
Anychart
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Prev. Close
6.5184
Open
6.5184
High
6.5184
Low
6.5184
52 wk Range
6.1-17.2032
Market Cap
4 796 M
P/E Ratio
16.7073
Shares Outstanding
623 M
Revenue
502 945 M
Dividends (Yield)
0.0319
Beta
0.676
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SYSMEX CORP.UNSP.ADR 1/2 data using free add-ons & libraries
Get SYSMEX CORP.UNSP.ADR 1/2 Fundamental Data
SYSMEX CORP.UNSP.ADR 1/2 Fundamental data includes:
- Net Revenue: 502 945 M
- EBITDA: 117 262 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-10
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SYSMEX CORP.UNSP.ADR 1/2 News
New
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics
Company Logo By 2033, the Point of Care (POC) Diagnostics market is projected to reach a valuation of approximately US$ 105.22 billion, driven by an 8.60% CAGR from 2025. This robust growth is fueled...
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
MINATO-KU, TOKYO, Japan & KOBE, Japan, February 05, 2026--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; "Fujirebio"), a consolidated subsidiary of H....
GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex
Company Logo The GCC Liquid Biopsy Market is projected to grow from US$ 98.24 million in 2024 to US$ 309.53 million by 2033, at a CAGR of 13.60%. This rapid growth is driven by rising cancer incidenc...
Is There Now an Opportunity in Sysmex After Recent Five Year Lows?
Trying to figure out your next move with Sysmex? You are definitely not alone. Whether you are holding, considering an entry, or thinking about a sharp exit, the stock has been front and center for in...
Get SYSMEX CORP.UNSP.ADR 1/2 fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
